These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35435328)

  • 1. Anti-Oxidative and Anti-Inflammatory Micelles: Break the Dry Eye Vicious Cycle.
    Li S; Lu Z; Huang Y; Wang Y; Jin Q; Shentu X; Ye J; Ji J; Yao K; Han H
    Adv Sci (Weinh); 2022 Jun; 9(17):e2200435. PubMed ID: 35435328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Atom Nanozyme Eye Drops Attenuate Inflammation and Break the Vicious Cycle in Dry Eye Disease.
    Chu D; Zhao M; Rong S; Jhe W; Cai X; Xiao Y; Zhang W; Geng X; Li Z; Zhang X; Li J
    Nanomicro Lett; 2024 Feb; 16(1):120. PubMed ID: 38372846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive dry eye therapy: overcoming ocular surface barrier and combating inflammation, oxidation, and mitochondrial damage.
    Xia Y; Zhang Y; Du Y; Wang Z; Cheng L; Du Z
    J Nanobiotechnology; 2024 May; 22(1):233. PubMed ID: 38725011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochanin A: Disrupting the inflammatory vicious cycle for dry eye disease.
    Chen T; Zhou N; Liang Q; Li Q; Li B; Chu Y; Zhang D; Chen Z; Tsao JR; Feng X; Hu K
    Eur J Pharmacol; 2024 Aug; 977():176583. PubMed ID: 38679123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROS-responsive celastrol-nanomedicine alleviates inflammation for dry eye disease.
    Cui B; Zhang N; Zhang W; Ning Q; Wang X; Feng H; Liu R; Li Z; Li J
    Nanotechnology; 2024 Jun; 35(33):. PubMed ID: 38829163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosmarinic acid-grafted gelatin nanogels for efficient diquafosol delivery in dry eye disease therapy.
    Zhou T; Li S; Zhu J; Zeng G; Lv Z; Zhang M; Yao K; Han H
    J Control Release; 2024 Sep; 373():306-318. PubMed ID: 39004103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease.
    Li YJ; Luo LJ; Harroun SG; Wei SC; Unnikrishnan B; Chang HT; Huang YF; Lai JY; Huang CC
    Nanoscale; 2019 Mar; 11(12):5580-5594. PubMed ID: 30860532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-ROS-scavenging and dual-lingering nanozyme-based eye drops alleviate dry eye disease.
    Zhang W; Zhao M; Chu D; Chen H; Cui B; Ning Q; Wang X; Li Z; Cao S; Li J
    J Nanobiotechnology; 2024 May; 22(1):229. PubMed ID: 38720321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tissue-adhesive F127 hydrogel delivers antioxidative copper-selenide nanoparticles for the treatment of dry eye disease.
    Ou L; Wu Z; Hu X; Huang J; Yi Z; Gong Z; Li H; Peng K; Shu C; Koole LH
    Acta Biomater; 2024 Feb; 175():353-368. PubMed ID: 38110136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional cerium oxide nanozymes with high ocular surface retention for dry eye disease treatment achieved by restoring redox balance.
    Zou H; Hong Y; Xu B; Wang M; Xie H; Lin Q
    Acta Biomater; 2024 Sep; 185():441-455. PubMed ID: 38997079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
    Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal collagen as a potential therapeutic target in dry eye disease.
    Baratta RO; Schlumpf E; Buono BJD; DeLorey S; Calkins DJ
    Surv Ophthalmol; 2022; 67(1):60-67. PubMed ID: 33882269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin ameliorates oxidative stress-mediated injuries through induction of HO-1 and restores autophagic flux in dry eye.
    Wang B; Zuo X; Peng L; Wang X; Zeng H; Zhong J; Li S; Xiao Y; Wang L; Ouyang H; Yuan J
    Exp Eye Res; 2021 Apr; 205():108491. PubMed ID: 33587908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect and mechanism of action of pterostilbene nano drugs in dry eye models.
    Li K; Lin M; Huang K; Han J; Wei L; Miao L; Chen H; Gong Q; Li X; Hu L
    Exp Eye Res; 2024 Apr; 241():109836. PubMed ID: 38387712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The core mechanism of dry eye disease is inflammation.
    Wei Y; Asbell PA
    Eye Contact Lens; 2014 Jul; 40(4):248-56. PubMed ID: 25390549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoceria-Mediated Cyclosporin A Delivery for Dry Eye Disease Management through Modulating Immune-Epithelial Crosstalk.
    Cui W; Chen S; Hu T; Zhou T; Qiu C; Jiang L; Cheng X; Ji J; Yao K; Han H
    ACS Nano; 2024 Apr; 18(17):11084-11102. PubMed ID: 38632691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconsidering the central role of mucins in dry eye and ocular surface diseases.
    Baudouin C; Rolando M; Benitez Del Castillo JM; Messmer EM; Figueiredo FC; Irkec M; Van Setten G; Labetoulle M
    Prog Retin Eye Res; 2019 Jul; 71():68-87. PubMed ID: 30471351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of Nitrogen-Doped Graphene Quantum Dots to Neutralize ROS and Modulate Intracellular Antioxidant Pathways to Improve Dry Eye Disease Therapy.
    Wu Z; Xia W; Ou L; Zheng L; Hou B; Pan T; Sun W; Koole LH; Shao Y; Qi L
    Int J Nanomedicine; 2024; 19():2691-2708. PubMed ID: 38510793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of
    Yang CC; Chien JY; Chou YY; Ciou JW; Huang SP
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013601
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-Inflammatories in the Treatment of Dry Eye Disease: A Review.
    Perez VL; Mah FS; Willcox M; Pflugfelder S
    J Ocul Pharmacol Ther; 2023 Mar; 39(2):89-101. PubMed ID: 36796014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.